ASX Stock

At Trader Dealer we understand the importance of information. You can use our handy company information finder to get key fundamental data about any company listed on the ASX.

Simply enter the stock code or the name of the company you are interested in for ASX share price information, company size, research analyst forecast, share and financial ratios, as well as a business and financial summary.

Don’t know the ASX code of the stock you want? Just click on the letter below for a full alphabetical listing.


Enter ASX Stock Code

Bookmark Page !



View all Companies by Letters

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


 
 

Starpharma Holdings Limited
Industry Group: Biotechnology / Medical Research - Biotechnology

Trade Online with Trader Dealer

Sorry, No Chart Available.

Business Summary
Starpharma Holdings Limited (SPL) is a biotechnology company engaged in the development of dendrimer products for pharmaceutical, life science and other applications. Activities within the Company are directed towards the development of nano-scale materials, with a particular focus on the development of its topical vaginal microbicide VivaGel for the treatment and prevention of bacterial vaginosis (BV); prevention of transmission of sexually transmitted infection (STIs), including human immunodeficiency virus (HIV) and genital herpes, and the application of dendrimers to drug delivery and other life science applications. Through partners, it is exploring dendrimer opportunities in materials science with applications in areas such as cosmetics, agrochemicals, coatings, adhesives and water. As of June 30, 2011, it had three Australian subsidiaries, such as Starpharma Pty Ltd, Angiostar Pty Limited and Viralstar Pty Limited, and one United States-based subsidiary, DNT, Inc.

Financial Summary
BRIEF: For the six months ended 31 December 2011, Starpharma Holdings Ltd's revenue decreased 2% to A$1M. Net loss increased 10% to A$4.7M. Revenues reflect a decrease in royalty, customer & license income and lower other income. Net loss also reflects an increase in research & development charges. The Company's engaged in the development of dendrimer products for pharmaceutical, life science and other applications.

Business Address


Level 6,
MELBOURNE, VIC 3004
Phone: 61-3-85322700
Fax: 61-3-95105955
http://www.starpharma.com/

ASX Share Price Information
Current Price 1.435
Current Price Date 22/02/2012
52 Week Hi/Low 1.69 - 0.92
Avg Volume Last ten Days 0.18
ASX Company Sizing
Market Cap 402.85
Revenues 384.00
EBITDA -7.38
Net Income -8.93
Number of Employees 52
Enterprise Value 384.00
Research Analyst Forecast
Consensus Recommendation Outperform
Target Price 1.96667
LT Growth Rate -
Projected P/E -34.78788
Sales 2.91600
EPS -0.04125
Profit -10.95150
DPS 0.00000
Share Ratios
EPS -0.03682
RPS 0.01362
BV per Share 0.11178
Cash per Share 0.07636
Cashflow per Share -0.03050
Cashflow per Share 0.00000
Financial Ratios
Gross Margin 100.00000
ROE -28.55909
Price/Sales 121.96520
P/E -
P/Book 12.83761